Jinzhuang Liao
Tongzipo Road 138
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Gracillin overcomes osimertinib resistance in NSCLC via dual inhibition of EGFR and Mcl-1.
Journal: Cancer gene therapy
Published: October 13, 2025
Demethoxycurcumin suppresses HK2-mediated glycolysis by targeting PTEN/Akt signaling.
Journal: Cancer gene therapy
Published: May 20, 2025
Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity.
Journal: Cancer gene therapy
Published: February 04, 2025
E3 ligase Skp2-mediated stabilization of survivin contributes to radioresistance.
Journal: Cell death discovery
Published: November 14, 2024
Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.
Journal: International journal of biological sciences
Published: September 19, 2024
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.
Journal: Cell death discovery
Published: July 15, 2024
Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin.
Journal: The American journal of Chinese medicine
Published: November 06, 2023
Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin.
Journal: Journal of Cancer
Published: September 04, 2023
Survivin degradation by bergenin overcomes pemetrexed resistance.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 24, 2023
TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance.
Journal: International journal of biological sciences
Published: June 15, 2023
Gastrodin destabilizes survivin and overcomes pemetrexed resistance.
Journal: Cellular signalling
Published: June 05, 2023
Last Updated: 09/26/2026